Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin
US5460813A · kind A · utility
10Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 1993 |
| Grant date | Oct 24, 1995 |
| Priority date | — |
| Expiry date | Apr 5, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/092
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to various methodologies for diagnosing Kawasaki syndrome. Various bacteria, including TSST-1 producing Staphylococcus aureus, and SPEB and SPEC producing streptococcus have been found to be indicative of the pathological condition. Also described is a Kawasaki syndrome implicated isolate of S. aureus, and therapeutic methodologies for preventing treating the condition. These involve the administration of anti-TSST-1 agents which are not gamma globulin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.